nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—NR3C1—Mometasone—systemic scleroderma	0.142	0.324	CbGbCtD
Spironolactone—Testolactone—Mometasone—systemic scleroderma	0.063	0.136	CrCrCtD
Spironolactone—Fluoxymesterone—Mometasone—systemic scleroderma	0.0579	0.125	CrCrCtD
Spironolactone—Fludrocortisone—Mometasone—systemic scleroderma	0.0564	0.121	CrCrCtD
Spironolactone—Potassium Canrenoate—Prednisone—systemic scleroderma	0.0497	0.107	CrCrCtD
Spironolactone—CYP2C8—Mometasone—systemic scleroderma	0.0487	0.111	CbGbCtD
Spironolactone—Hydrocortisone—Mometasone—systemic scleroderma	0.046	0.0989	CrCrCtD
Spironolactone—NR3C1—Prednisone—systemic scleroderma	0.0451	0.103	CbGbCtD
Spironolactone—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0403	0.0921	CbGbCtD
Spironolactone—SLCO1A2—Prednisone—systemic scleroderma	0.0389	0.0888	CbGbCtD
Spironolactone—Hydrocortamate—Prednisone—systemic scleroderma	0.0365	0.0785	CrCrCtD
Spironolactone—Cortisone acetate—Prednisone—systemic scleroderma	0.0354	0.0761	CrCrCtD
Spironolactone—Testolactone—Prednisone—systemic scleroderma	0.0343	0.0739	CrCrCtD
Spironolactone—Fludrocortisone—Prednisone—systemic scleroderma	0.0308	0.0661	CrCrCtD
Spironolactone—Methyltestosterone—Prednisone—systemic scleroderma	0.03	0.0645	CrCrCtD
Spironolactone—Hydrocortisone—Prednisone—systemic scleroderma	0.0251	0.0539	CrCrCtD
Spironolactone—ABCB1—Lisinopril—systemic scleroderma	0.0223	0.0509	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—systemic scleroderma	0.0195	0.0445	CbGbCtD
Spironolactone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0194	0.0443	CbGbCtD
Spironolactone—ABCB1—Captopril—systemic scleroderma	0.0167	0.0381	CbGbCtD
Spironolactone—ABCC2—Methotrexate—systemic scleroderma	0.0162	0.0369	CbGbCtD
Spironolactone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0131	0.03	CbGbCtD
Spironolactone—ABCB1—Prednisone—systemic scleroderma	0.0105	0.024	CbGbCtD
Spironolactone—ABCB1—Methotrexate—systemic scleroderma	0.00527	0.012	CbGbCtD
Spironolactone—PGR—artery—systemic scleroderma	0.00119	0.112	CbGeAlD
Spironolactone—PGR—blood vessel—systemic scleroderma	0.000931	0.0871	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.000532	0.00614	CcSEcCtD
Spironolactone—Cramps of lower extremities—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00613	CcSEcCtD
Spironolactone—SHBG—connective tissue—systemic scleroderma	0.00053	0.0496	CbGeAlD
Spironolactone—Renal failure acute—Lisinopril—systemic scleroderma	0.000519	0.00599	CcSEcCtD
Spironolactone—Gynaecomastia—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00597	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.000517	0.00597	CcSEcCtD
Spironolactone—Muscle spasms—Pentoxifylline—systemic scleroderma	0.000517	0.00597	CcSEcCtD
Spironolactone—NR3C2—connective tissue—systemic scleroderma	0.000513	0.0481	CbGeAlD
Spironolactone—Renal failure—Captopril—systemic scleroderma	0.000513	0.00592	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.000502	0.0058	CcSEcCtD
Spironolactone—Cramp muscle—Leflunomide—systemic scleroderma	0.000502	0.0058	CcSEcCtD
Spironolactone—Ataxia—Mycophenolic acid—systemic scleroderma	0.0005	0.00577	CcSEcCtD
Spironolactone—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.000499	0.00576	CcSEcCtD
Spironolactone—Gastritis—Leflunomide—systemic scleroderma	0.000493	0.0057	CcSEcCtD
Spironolactone—Agranulocytosis—Captopril—systemic scleroderma	0.000487	0.00562	CcSEcCtD
Spironolactone—Malaise—Pentoxifylline—systemic scleroderma	0.000485	0.0056	CcSEcCtD
Spironolactone—Leukopenia—Pentoxifylline—systemic scleroderma	0.000481	0.00556	CcSEcCtD
Spironolactone—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.000479	0.00553	CcSEcCtD
Spironolactone—Eosinophilia—Leflunomide—systemic scleroderma	0.000477	0.00551	CcSEcCtD
Spironolactone—PGR—connective tissue—systemic scleroderma	0.000477	0.0447	CbGeAlD
Spironolactone—Gastritis—Mycophenolic acid—systemic scleroderma	0.000471	0.00544	CcSEcCtD
Spironolactone—NR3C2—smooth muscle tissue—systemic scleroderma	0.00047	0.044	CbGeAlD
Spironolactone—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00525	CcSEcCtD
Spironolactone—Discomfort—Pentoxifylline—systemic scleroderma	0.000452	0.00522	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.000451	0.00521	CcSEcCtD
Spironolactone—Ataxia—Lisinopril—systemic scleroderma	0.000451	0.0052	CcSEcCtD
Spironolactone—Amenorrhoea—Prednisone—systemic scleroderma	0.000446	0.00515	CcSEcCtD
Spironolactone—Erythema multiforme—Captopril—systemic scleroderma	0.000443	0.00511	CcSEcCtD
Spironolactone—Confusional state—Pentoxifylline—systemic scleroderma	0.000442	0.00511	CcSEcCtD
Spironolactone—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000439	0.00507	CcSEcCtD
Spironolactone—PGR—smooth muscle tissue—systemic scleroderma	0.000436	0.0409	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.000431	0.00498	CcSEcCtD
Spironolactone—Cramp muscle—Lisinopril—systemic scleroderma	0.000431	0.00498	CcSEcCtD
Spironolactone—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00043	0.00496	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.000426	0.00492	CcSEcCtD
Spironolactone—Agranulocytosis—Azathioprine—systemic scleroderma	0.000425	0.0049	CcSEcCtD
Spironolactone—Gastritis—Lisinopril—systemic scleroderma	0.000424	0.0049	CcSEcCtD
Spironolactone—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.000423	0.00489	CcSEcCtD
Spironolactone—Renal failure—Leflunomide—systemic scleroderma	0.000422	0.00488	CcSEcCtD
Spironolactone—Ulcer—Prednisone—systemic scleroderma	0.000414	0.00479	CcSEcCtD
Spironolactone—Alopecia—Captopril—systemic scleroderma	0.000414	0.00478	CcSEcCtD
Spironolactone—Eosinophilia—Lisinopril—systemic scleroderma	0.00041	0.00473	CcSEcCtD
Spironolactone—Renal failure—Mycophenolic acid—systemic scleroderma	0.000403	0.00465	CcSEcCtD
Spironolactone—Vasculitis—Prednisone—systemic scleroderma	0.000402	0.00464	CcSEcCtD
Spironolactone—Agranulocytosis—Leflunomide—systemic scleroderma	0.000401	0.00463	CcSEcCtD
Spironolactone—Somnolence—Pentoxifylline—systemic scleroderma	0.00039	0.0045	CcSEcCtD
Spironolactone—Erythema multiforme—Azathioprine—systemic scleroderma	0.000386	0.00446	CcSEcCtD
Spironolactone—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000383	0.00442	CcSEcCtD
Spironolactone—Erectile dysfunction—Lisinopril—systemic scleroderma	0.000381	0.0044	CcSEcCtD
Spironolactone—AR—connective tissue—systemic scleroderma	0.00038	0.0356	CbGeAlD
Spironolactone—Anaphylactic shock—Mometasone—systemic scleroderma	0.000379	0.00437	CcSEcCtD
Spironolactone—Ill-defined disorder—Captopril—systemic scleroderma	0.000378	0.00436	CcSEcCtD
Spironolactone—Gastritis—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00429	CcSEcCtD
Spironolactone—NR3C2—digestive system—systemic scleroderma	0.000371	0.0347	CbGeAlD
Spironolactone—Malaise—Captopril—systemic scleroderma	0.000367	0.00424	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000366	0.00423	CcSEcCtD
Spironolactone—Erythema multiforme—Leflunomide—systemic scleroderma	0.000365	0.00421	CcSEcCtD
Spironolactone—Renal failure—Lisinopril—systemic scleroderma	0.000363	0.00419	CcSEcCtD
Spironolactone—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000362	0.00417	CcSEcCtD
Spironolactone—Alopecia—Azathioprine—systemic scleroderma	0.000361	0.00417	CcSEcCtD
Spironolactone—NR3C2—tendon—systemic scleroderma	0.000353	0.033	CbGeAlD
Spironolactone—Urticaria—Pentoxifylline—systemic scleroderma	0.000349	0.00402	CcSEcCtD
Spironolactone—AR—smooth muscle tissue—systemic scleroderma	0.000348	0.0326	CbGeAlD
Spironolactone—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000347	0.004	CcSEcCtD
Spironolactone—Ulcer—Methotrexate—systemic scleroderma	0.000346	0.004	CcSEcCtD
Spironolactone—Agranulocytosis—Lisinopril—systemic scleroderma	0.000345	0.00398	CcSEcCtD
Spironolactone—AR—skin of body—systemic scleroderma	0.000343	0.0321	CbGeAlD
Spironolactone—Discomfort—Captopril—systemic scleroderma	0.000343	0.00396	CcSEcCtD
Spironolactone—Alopecia—Leflunomide—systemic scleroderma	0.000341	0.00394	CcSEcCtD
Spironolactone—Vasculitis—Methotrexate—systemic scleroderma	0.000336	0.00388	CcSEcCtD
Spironolactone—Confusional state—Captopril—systemic scleroderma	0.000335	0.00387	CcSEcCtD
Spironolactone—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00386	CcSEcCtD
Spironolactone—Anaphylactic shock—Captopril—systemic scleroderma	0.000333	0.00384	CcSEcCtD
Spironolactone—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00033	0.00381	CcSEcCtD
Spironolactone—Thrombocytopenia—Captopril—systemic scleroderma	0.000326	0.00376	CcSEcCtD
Spironolactone—Alopecia—Mycophenolic acid—systemic scleroderma	0.000325	0.00375	CcSEcCtD
Spironolactone—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000323	0.00373	CcSEcCtD
Spironolactone—Muscle spasms—Leflunomide—systemic scleroderma	0.000323	0.00373	CcSEcCtD
Spironolactone—Malaise—Azathioprine—systemic scleroderma	0.000321	0.0037	CcSEcCtD
Spironolactone—Leukopenia—Azathioprine—systemic scleroderma	0.000318	0.00367	CcSEcCtD
Spironolactone—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00367	CcSEcCtD
Spironolactone—SLCO1A2—digestive system—systemic scleroderma	0.000318	0.0298	CbGeAlD
Spironolactone—Erythema multiforme—Lisinopril—systemic scleroderma	0.000313	0.00362	CcSEcCtD
Spironolactone—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000312	0.0036	CcSEcCtD
Spironolactone—Pruritus—Pentoxifylline—systemic scleroderma	0.00031	0.00358	CcSEcCtD
Spironolactone—NR3C2—lung—systemic scleroderma	0.00031	0.029	CbGeAlD
Spironolactone—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000308	0.00356	CcSEcCtD
Spironolactone—Malaise—Leflunomide—systemic scleroderma	0.000303	0.0035	CcSEcCtD
Spironolactone—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00349	CcSEcCtD
Spironolactone—Leukopenia—Leflunomide—systemic scleroderma	0.000301	0.00347	CcSEcCtD
Spironolactone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.0003	0.00347	CcSEcCtD
Spironolactone—Body temperature increased—Mometasone—systemic scleroderma	0.000299	0.00346	CcSEcCtD
Spironolactone—Discomfort—Azathioprine—systemic scleroderma	0.000299	0.00345	CcSEcCtD
Spironolactone—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000297	0.00343	CcSEcCtD
Spironolactone—ABCC2—digestive system—systemic scleroderma	0.000296	0.0277	CbGeAlD
Spironolactone—Somnolence—Captopril—systemic scleroderma	0.000296	0.00341	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—systemic scleroderma	0.000293	0.00338	CcSEcCtD
Spironolactone—Alopecia—Lisinopril—systemic scleroderma	0.000293	0.00338	CcSEcCtD
Spironolactone—Lethargy—Prednisone—systemic scleroderma	0.00029	0.00335	CcSEcCtD
Spironolactone—Dizziness—Pentoxifylline—systemic scleroderma	0.00029	0.00335	CcSEcCtD
Spironolactone—Malaise—Mycophenolic acid—systemic scleroderma	0.000289	0.00334	CcSEcCtD
Spironolactone—PGR—lung—systemic scleroderma	0.000288	0.0269	CbGeAlD
Spironolactone—ABCB1—blood vessel—systemic scleroderma	0.000287	0.0269	CbGeAlD
Spironolactone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000287	0.00331	CcSEcCtD
Spironolactone—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000284	0.00328	CcSEcCtD
Spironolactone—Discomfort—Leflunomide—systemic scleroderma	0.000282	0.00326	CcSEcCtD
Spironolactone—ABCC2—tendon—systemic scleroderma	0.000282	0.0264	CbGeAlD
Spironolactone—Vomiting—Pentoxifylline—systemic scleroderma	0.000279	0.00322	CcSEcCtD
Spironolactone—Muscle spasms—Lisinopril—systemic scleroderma	0.000277	0.0032	CcSEcCtD
Spironolactone—Rash—Pentoxifylline—systemic scleroderma	0.000277	0.00319	CcSEcCtD
Spironolactone—Dermatitis—Pentoxifylline—systemic scleroderma	0.000276	0.00319	CcSEcCtD
Spironolactone—NR3C1—connective tissue—systemic scleroderma	0.000275	0.0258	CbGeAlD
Spironolactone—Headache—Pentoxifylline—systemic scleroderma	0.000275	0.00317	CcSEcCtD
Spironolactone—AR—digestive system—systemic scleroderma	0.000275	0.0257	CbGeAlD
Spironolactone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000274	0.00316	CcSEcCtD
Spironolactone—Feeling abnormal—Captopril—systemic scleroderma	0.000274	0.00316	CcSEcCtD
Spironolactone—Discomfort—Mycophenolic acid—systemic scleroderma	0.000269	0.00311	CcSEcCtD
Spironolactone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000268	0.0031	CcSEcCtD
Spironolactone—Pruritus—Mometasone—systemic scleroderma	0.000268	0.00309	CcSEcCtD
Spironolactone—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000268	0.00309	CcSEcCtD
Spironolactone—SLCO1A2—lung—systemic scleroderma	0.000265	0.0248	CbGeAlD
Spironolactone—Confusional state—Mycophenolic acid—systemic scleroderma	0.000264	0.00304	CcSEcCtD
Spironolactone—Body temperature increased—Captopril—systemic scleroderma	0.000263	0.00303	CcSEcCtD
Spironolactone—AR—tendon—systemic scleroderma	0.000261	0.0245	CbGeAlD
Spironolactone—Nausea—Pentoxifylline—systemic scleroderma	0.000261	0.00301	CcSEcCtD
Spironolactone—Malaise—Lisinopril—systemic scleroderma	0.00026	0.003	CcSEcCtD
Spironolactone—Diarrhoea—Mometasone—systemic scleroderma	0.000259	0.00299	CcSEcCtD
Spironolactone—Leukopenia—Lisinopril—systemic scleroderma	0.000258	0.00298	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—systemic scleroderma	0.000258	0.00297	CcSEcCtD
Spironolactone—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000257	0.00296	CcSEcCtD
Spironolactone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000256	0.00296	CcSEcCtD
Spironolactone—NR3C1—smooth muscle tissue—systemic scleroderma	0.000252	0.0236	CbGeAlD
Spironolactone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000251	0.00289	CcSEcCtD
Spironolactone—NR3C1—skin of body—systemic scleroderma	0.000249	0.0233	CbGeAlD
Spironolactone—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00281	CcSEcCtD
Spironolactone—Discomfort—Lisinopril—systemic scleroderma	0.000243	0.0028	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—systemic scleroderma	0.000243	0.0028	CcSEcCtD
Spironolactone—Vomiting—Mometasone—systemic scleroderma	0.000241	0.00278	CcSEcCtD
Spironolactone—Feeling abnormal—Azathioprine—systemic scleroderma	0.000239	0.00276	CcSEcCtD
Spironolactone—Rash—Mometasone—systemic scleroderma	0.000239	0.00276	CcSEcCtD
Spironolactone—Dermatitis—Mometasone—systemic scleroderma	0.000238	0.00275	CcSEcCtD
Spironolactone—Confusional state—Lisinopril—systemic scleroderma	0.000237	0.00274	CcSEcCtD
Spironolactone—Headache—Mometasone—systemic scleroderma	0.000237	0.00274	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000237	0.00273	CcSEcCtD
Spironolactone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000235	0.00272	CcSEcCtD
Spironolactone—Pruritus—Captopril—systemic scleroderma	0.000235	0.00272	CcSEcCtD
Spironolactone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00271	CcSEcCtD
Spironolactone—Somnolence—Mycophenolic acid—systemic scleroderma	0.000232	0.00268	CcSEcCtD
Spironolactone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000231	0.00266	CcSEcCtD
Spironolactone—Body temperature increased—Azathioprine—systemic scleroderma	0.000229	0.00265	CcSEcCtD
Spironolactone—AR—lung—systemic scleroderma	0.000229	0.0215	CbGeAlD
Spironolactone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000228	0.00263	CcSEcCtD
Spironolactone—Diarrhoea—Captopril—systemic scleroderma	0.000228	0.00263	CcSEcCtD
Spironolactone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000227	0.00262	CcSEcCtD
Spironolactone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000226	0.00261	CcSEcCtD
Spironolactone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000226	0.00261	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000226	0.00261	CcSEcCtD
Spironolactone—Nausea—Mometasone—systemic scleroderma	0.000225	0.0026	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—systemic scleroderma	0.000224	0.00258	CcSEcCtD
Spironolactone—Dizziness—Captopril—systemic scleroderma	0.00022	0.00254	CcSEcCtD
Spironolactone—Urticaria—Leflunomide—systemic scleroderma	0.000218	0.00251	CcSEcCtD
Spironolactone—Body temperature increased—Leflunomide—systemic scleroderma	0.000217	0.0025	CcSEcCtD
Spironolactone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000215	0.00249	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000214	0.00247	CcSEcCtD
Spironolactone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000214	0.00247	CcSEcCtD
Spironolactone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000213	0.00246	CcSEcCtD
Spironolactone—Vomiting—Captopril—systemic scleroderma	0.000211	0.00244	CcSEcCtD
Spironolactone—Rash—Captopril—systemic scleroderma	0.00021	0.00242	CcSEcCtD
Spironolactone—Dermatitis—Captopril—systemic scleroderma	0.000209	0.00242	CcSEcCtD
Spironolactone—Somnolence—Lisinopril—systemic scleroderma	0.000209	0.00242	CcSEcCtD
Spironolactone—Headache—Captopril—systemic scleroderma	0.000208	0.00241	CcSEcCtD
Spironolactone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000208	0.0024	CcSEcCtD
Spironolactone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000207	0.00239	CcSEcCtD
Spironolactone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00238	CcSEcCtD
Spironolactone—Eosinophilia—Methotrexate—systemic scleroderma	0.000204	0.00235	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000203	0.00235	CcSEcCtD
Spironolactone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00233	CcSEcCtD
Spironolactone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000202	0.00233	CcSEcCtD
Spironolactone—NR3C1—digestive system—systemic scleroderma	0.000199	0.0186	CbGeAlD
Spironolactone—Diarrhoea—Azathioprine—systemic scleroderma	0.000199	0.00229	CcSEcCtD
Spironolactone—Nausea—Captopril—systemic scleroderma	0.000198	0.00228	CcSEcCtD
Spironolactone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000194	0.00224	CcSEcCtD
Spironolactone—Pruritus—Leflunomide—systemic scleroderma	0.000194	0.00224	CcSEcCtD
Spironolactone—Dizziness—Azathioprine—systemic scleroderma	0.000192	0.00222	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000189	0.00219	CcSEcCtD
Spironolactone—NR3C1—tendon—systemic scleroderma	0.000189	0.0177	CbGeAlD
Spironolactone—Diarrhoea—Leflunomide—systemic scleroderma	0.000188	0.00216	CcSEcCtD
Spironolactone—Urticaria—Lisinopril—systemic scleroderma	0.000187	0.00216	CcSEcCtD
Spironolactone—Body temperature increased—Lisinopril—systemic scleroderma	0.000186	0.00215	CcSEcCtD
Spironolactone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000185	0.00214	CcSEcCtD
Spironolactone—Vomiting—Azathioprine—systemic scleroderma	0.000185	0.00213	CcSEcCtD
Spironolactone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00212	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—systemic scleroderma	0.000183	0.00212	CcSEcCtD
Spironolactone—Rash—Azathioprine—systemic scleroderma	0.000183	0.00211	CcSEcCtD
Spironolactone—Dermatitis—Azathioprine—systemic scleroderma	0.000183	0.00211	CcSEcCtD
Spironolactone—Headache—Azathioprine—systemic scleroderma	0.000182	0.0021	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000182	0.0021	CcSEcCtD
Spironolactone—Dizziness—Leflunomide—systemic scleroderma	0.000181	0.00209	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—systemic scleroderma	0.00018	0.00208	CcSEcCtD
Spironolactone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000179	0.00207	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00206	CcSEcCtD
Spironolactone—Vomiting—Leflunomide—systemic scleroderma	0.000174	0.00201	CcSEcCtD
Spironolactone—Alopecia—Prednisone—systemic scleroderma	0.000174	0.00201	CcSEcCtD
Spironolactone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000173	0.002	CcSEcCtD
Spironolactone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000173	0.002	CcSEcCtD
Spironolactone—Rash—Leflunomide—systemic scleroderma	0.000173	0.002	CcSEcCtD
Spironolactone—Dermatitis—Leflunomide—systemic scleroderma	0.000173	0.00199	CcSEcCtD
Spironolactone—Nausea—Azathioprine—systemic scleroderma	0.000172	0.00199	CcSEcCtD
Spironolactone—Headache—Leflunomide—systemic scleroderma	0.000172	0.00198	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000171	0.00197	CcSEcCtD
Spironolactone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00196	CcSEcCtD
Spironolactone—Pruritus—Lisinopril—systemic scleroderma	0.000167	0.00192	CcSEcCtD
Spironolactone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000166	0.00192	CcSEcCtD
Spironolactone—NR3C1—lung—systemic scleroderma	0.000166	0.0155	CbGeAlD
Spironolactone—Rash—Mycophenolic acid—systemic scleroderma	0.000165	0.0019	CcSEcCtD
Spironolactone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000165	0.0019	CcSEcCtD
Spironolactone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000164	0.00189	CcSEcCtD
Spironolactone—Headache—Mycophenolic acid—systemic scleroderma	0.000164	0.00189	CcSEcCtD
Spironolactone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00188	CcSEcCtD
Spironolactone—Nausea—Leflunomide—systemic scleroderma	0.000163	0.00188	CcSEcCtD
Spironolactone—Diarrhoea—Lisinopril—systemic scleroderma	0.000161	0.00186	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000159	0.00184	CcSEcCtD
Spironolactone—Dizziness—Lisinopril—systemic scleroderma	0.000156	0.0018	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000156	0.0018	CcSEcCtD
Spironolactone—Nausea—Mycophenolic acid—systemic scleroderma	0.000155	0.00179	CcSEcCtD
Spironolactone—Malaise—Prednisone—systemic scleroderma	0.000155	0.00178	CcSEcCtD
Spironolactone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00176	CcSEcCtD
Spironolactone—Vomiting—Lisinopril—systemic scleroderma	0.00015	0.00173	CcSEcCtD
Spironolactone—Rash—Lisinopril—systemic scleroderma	0.000148	0.00171	CcSEcCtD
Spironolactone—Dermatitis—Lisinopril—systemic scleroderma	0.000148	0.00171	CcSEcCtD
Spironolactone—Headache—Lisinopril—systemic scleroderma	0.000148	0.0017	CcSEcCtD
Spironolactone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00169	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—systemic scleroderma	0.000145	0.00168	CcSEcCtD
Spironolactone—Discomfort—Prednisone—systemic scleroderma	0.000144	0.00166	CcSEcCtD
Spironolactone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00163	CcSEcCtD
Spironolactone—Nausea—Lisinopril—systemic scleroderma	0.00014	0.00161	CcSEcCtD
Spironolactone—Anaphylactic shock—Prednisone—systemic scleroderma	0.00014	0.00161	CcSEcCtD
Spironolactone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00158	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000133	0.00153	CcSEcCtD
Spironolactone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00151	CcSEcCtD
Spironolactone—Rash—Mycophenolate mofetil—systemic scleroderma	0.00013	0.0015	CcSEcCtD
Spironolactone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00013	0.0015	CcSEcCtD
Spironolactone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00149	CcSEcCtD
Spironolactone—Malaise—Methotrexate—systemic scleroderma	0.000129	0.00149	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—systemic scleroderma	0.000128	0.00148	CcSEcCtD
Spironolactone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00141	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—systemic scleroderma	0.00012	0.00139	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—systemic scleroderma	0.000118	0.00136	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000117	0.00135	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisone—systemic scleroderma	0.000115	0.00133	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000114	0.00132	CcSEcCtD
Spironolactone—Urticaria—Prednisone—systemic scleroderma	0.000111	0.00128	CcSEcCtD
Spironolactone—Body temperature increased—Prednisone—systemic scleroderma	0.000111	0.00128	CcSEcCtD
Spironolactone—ABCB1—digestive system—systemic scleroderma	0.000106	0.00997	CbGeAlD
Spironolactone—Somnolence—Methotrexate—systemic scleroderma	0.000104	0.0012	CcSEcCtD
Spironolactone—Hypersensitivity—Prednisone—systemic scleroderma	0.000103	0.00119	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000101	0.00117	CcSEcCtD
Spironolactone—Pruritus—Prednisone—systemic scleroderma	9.89e-05	0.00114	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—systemic scleroderma	9.63e-05	0.00111	CcSEcCtD
Spironolactone—Diarrhoea—Prednisone—systemic scleroderma	9.57e-05	0.0011	CcSEcCtD
Spironolactone—Urticaria—Methotrexate—systemic scleroderma	9.29e-05	0.00107	CcSEcCtD
Spironolactone—Dizziness—Prednisone—systemic scleroderma	9.25e-05	0.00107	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—systemic scleroderma	9.24e-05	0.00107	CcSEcCtD
Spironolactone—Vomiting—Prednisone—systemic scleroderma	8.89e-05	0.00103	CcSEcCtD
Spironolactone—ABCB1—lung—systemic scleroderma	8.89e-05	0.00832	CbGeAlD
Spironolactone—Rash—Prednisone—systemic scleroderma	8.82e-05	0.00102	CcSEcCtD
Spironolactone—Dermatitis—Prednisone—systemic scleroderma	8.81e-05	0.00102	CcSEcCtD
Spironolactone—Headache—Prednisone—systemic scleroderma	8.76e-05	0.00101	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—systemic scleroderma	8.61e-05	0.000994	CcSEcCtD
Spironolactone—Nausea—Prednisone—systemic scleroderma	8.31e-05	0.000959	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—systemic scleroderma	8.27e-05	0.000955	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—systemic scleroderma	8e-05	0.000923	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—systemic scleroderma	7.73e-05	0.000892	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—systemic scleroderma	7.43e-05	0.000858	CcSEcCtD
Spironolactone—Rash—Methotrexate—systemic scleroderma	7.37e-05	0.000851	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—systemic scleroderma	7.36e-05	0.00085	CcSEcCtD
Spironolactone—Headache—Methotrexate—systemic scleroderma	7.32e-05	0.000845	CcSEcCtD
Spironolactone—Nausea—Methotrexate—systemic scleroderma	6.94e-05	0.000802	CcSEcCtD
